Introduction {#S1}
============

As a substantial worldwide health problem, chronic back pain (CBP) is one of the most frequent complaints and the second most common symptom reported by patients during their primary physical care visits ([@B50]; [@B76]). Being more prevalent in females ([@B38]; [@B48]), CBP has been introduced as the first leading cause of years of lived with disability (YLDs) in 2016, with the incidence of 57.6 million YLDs all over the world ([@B77]). In western countries, the prevalence of lifetime CBP ranges from 49% to 70% ([@B42]), seriously impairing the quality of life in these patients ([@B60]). In addition, CBP imposes considerable socio-economic burdens and leads to rigorous challenges for healthcare program developments ([@B76]; [@B18]).

It is widely accepted that CBP can be caused by anatomical abnormalities or systemic diseases in/around the spinal cord (i.e., peripheral level), including lesions or degenerations in certain structures of the spine ([@B19]; [@B21]). Therefore, in the diagnosis and treatment of CBP, it is reasonable that clinicians commonly focus on the "end organ dysfunction," where structural and functional abnormalities could be found within the musculoskeletal system ([@B62]; [@B79]). However, a specific pathoanatomical diagnosis of the pain generators cannot be precisely identified in 90% of CBP patients with apparent symptoms ([@B42]; [@B48]), i.e., most CBP patients are non-specific, and characterized by a range of biophysical, psychological, and social factors with an extreme variability in genesis ([@B33]). Therefore, it remains difficult to accurately diagnose and evaluate non-specific CBP to date. Consequently, there is no doubt that such imprecise diagnosis and evaluation of CBP hamper the individualized intervention based on the etiology of the disease itself ([@B78]; [@B56]), leading to the prolongation of treatment duration and the deterioration of the health condition in patients ([@B36]; [@B16]).

Theoretically, the imprecise diagnosis of CBP could be caused by the possible dissociation between nociception (nociceptive inputs caused by injuries or diseases at the peripheral level) and pain (a conscious experience in the brain) ([@B17]; [@B47]; [@B52]; [@B39]). Pain can occur in the absence of nociception, and the link between nociception and pain is heavily dependent on various factors, including cognitive condition (e.g., attention, expectation, and context) and emotional state/trait (e.g., depression, anxiety, and catastrophizing) ([@B47]; [@B59]). Based on these theoretical perspectives, accumulating evidence has revealed potential obstacles in diagnosis and treatment of CBP, spanning from the aspects of structural ([@B3]; [@B64]; [@B5]; [@B66], [@B65]; [@B41]; [@B26]), functional ([@B27]; [@B4], [@B8]; [@B66]; [@B12]; [@B51]; [@B81]; [@B58]; [@B37]; [@B44]), to metabolic abnormalities in the brain ([@B28], [@B29], [@B30], [@B31]; [@B32]). Since the properties of the peripheral injury or disease are insufficient to characterize CBP, it would be important to evaluate the cortical abnormalities for a better understanding of the causes and consequences of CBP ([@B79]; [@B55]).

In clinical practice, an integrated diagnosis strategy that not only assesses injuries or diseases in/around the spinal cord but also evaluates cortical abnormalities is highly needed to optimize the treatment strategies for CBP patients, especially for non-specific CBP patients. In the present study, we overviewed findings in recent research that evaluates cortical abnormalities in CBP patients using advanced neuroimaging techniques, and discussed some perspectives on how to improve the diagnosis of the disease (please note that there are not enough studies exploring cortical abnormalities in specific CBP patients, and the possible differences of brain alterations in specific and non-specific CBP patients are not considered in the present study).

Cortical Evaluations Using Neuroimaging Techniques {#S2}
==================================================

Several non-invasive neuroimaging techniques with different underlying physical principles are widely adopted to evaluate the cortical abnormalities in CBP patients ([@B1]; [@B15]), including structural and functional magnetic resonance imaging (MRI; [Table 1](#T1){ref-type="table"}), electroencephalography (EEG; [Table 2](#T2){ref-type="table"}), magnetoencephalography (MEG; [Table 2](#T2){ref-type="table"}), and magnetic resonance spectroscopy (MRS; [Table 3](#T3){ref-type="table"}). In the following sections, we provided a comprehensive review of recent studies that investigated brain alterations in CBP patients by these techniques.

###### 

Evaluation of cortical alterations in CBP patients using structural and functional MRI techniques.

  **Author, year**   **Scan type**                      **Patients**                                                        **Controls**                                  **Stimulation**                                     **Targets**                                                                        **Main findings (patients compared with controls)**
  ------------------ ---------------------------------- ------------------------------------------------------------------- --------------------------------------------- --------------------------------------------------- ---------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B3]              Structural MRI                     26 CBP (in two subgroups of neuropathic and non-neuropathic pain)   26 Healthy controls                           Nil                                                 Neocortical GM volume, Regional GM density                                         •5--11% less neocortical GM volume in CBP patients associated with pain duration•Reduced GM density in bilateral dlPFC and right thalamus, correlated with pain features in neuropathic and non-neuropathic conditions
  [@B5]              Structural MRI                     36 CBP, 28 CRPS, and 20 knee OA                                     46 Healthy controls                           Nil                                                 Total GM volume, regional GM density                                               •Altered total GM volume only in CBP patients•Specific patterns of reduced GM density for each chronic pain condition based on voxel-wise and gross regional analyses•Significant decrease in GM density of some regions, such as the primary sensory, motor regions, hippocampus, visual cortex, and bilateral INS cortex after longer pain duration•Relating GM density reductions to chronicity of pain
  [@B26]             Structural MRI                     111 CBP                                                             432 Healthy controls                          Nil                                                 Regional GM density                                                                •Decreased GM in the vlPFC, dlPFC, vmPFC, dmPFC, and anterior INS in patients•A weak negative correlation between pain severity and GM volume in the left dlPFC, vlPFC, and ACC
  [@B41]             Structural MRI                     14 CLBP                                                             14 Healthy controls                           Nil                                                 Total GM volume, total WM volume, and regional GM density                          •Decreased total GM volume•Decreased total WM volume•Decreased GM density in areas associated with pain processing and modulation such as dlPFC, thalamus, and MCC
  [@B64]             Structural MRI                     18 CBP                                                              18 healthy controls                           Nil                                                 Regional GM density                                                                •Decreased GM in the brainstem and the somatosensory cortex•A negative correlation between pain intensity and decreased GM in these brain areas•Increased GM in the basal ganglia bilaterally and the left thalamus
  [@B66]             Structural MRI and task fMRI       18 CLBP and 14 CLBP six months after treatment                      16 Healthy controls (10 controls revisited)   MSIT                                                Total GM volume, total WM volume, and partial volume estimation                    •Thinner brain cortex in the left dlPFC before treatment•Increased cortical thickness in the left dlPFC after treatment, correlated with the reduction in both pain and physical disability•Increased thickness in the primary motor cortex, correlated with reduced physical disability•Increased thickness in the right anterior INS, correlated with reduced pain•Abnormal left dlPFC activity in task-fMRI evaluations before treatment•Normalized left dlPFC activity in task-fMRI evaluations after treatment
  [@B4]              Resting state fMRI                 15 CBP                                                              15 Healthy controls                           Nil                                                 BOLD fluctuations across different frequencies in different regions of the brain   •Strong low frequency power in the lateral parietal regions, mPFC, PCC, and visual regions•Middle frequency power in middle portions of the ACC, bilateral INS, and subcortical nuclei, including the basal ganglia and thalamus•High frequency power located in the ACC, INS, subcortical regions, temporal poles, and hippocampal formation•A correlation between mPFC aberrant BOLD high frequency dynamics and changed functional connectivity to pain signaling/modulating brain regions
  [@B8]              Resting state fMRI                 18 CBP, 19 CRPS, and 14 knee OA                                     36 Healthy controls                           Nil                                                 ROI and BOLD analysis                                                              •Decreased connectivity of the mPFC to the posterior constituents of the DMN in all patients•Increased connectivity to the INS cortex in proportion to the intensity of pain in all patients•Increased high frequency oscillations in multiple DMN regions, such as the mPFC•Correlation between both phase and frequency alterations and pain duration in OA and CBP patients
  [@B44]             Resting state fMRI                 17 CLBP                                                             16 Healthy controls                           Nil                                                 Positive and negative moods altered DMN fMRI patterns                              •Significant sadness \> baseline interaction in clusters spanning the parietal operculum/postcentral gyrus, INS cortices, ACC, frontal pole, and a portion of the cerebellum•Significant happiness \> baseline only in cluster covering a portion of the cerebellum
  [@B58]             Resting state fMRI and Task fMRI   17 NSLBP                                                            17 Healthy controls                           Nil                                                 Sensorimotor functional connectivity and STSTS performance                         •Increased time to perform the STSTS task in patients•Decreased resting-state functional connectivity of brain regions associated with sensory and/or motor information integration such as lobule IV and V of the left cerebellum and left precentral gyrus in patients•Decreased functional connectivity correlated with a longer duration of the STSTS task in both NSLBP patients and healthy subjects
  [@B81]             Resting state fMRI                 18 CLBP                                                             18 Healthy controls                           Nil                                                 Brain resting state PAG-FC alterations                                             •Increased FC between the PAG and vmPFC/rACC•Negative correlations between pain scores and FC in PAG-vmPFC/rACC after pain-induction maneuver in patients•Negative correlations between CLBP duration and PAG-INS and PAG-amygdala FC before pain-induction maneuver in the patient
  [@B12]             Resting state fMRI and Task fMRI   22 CBP                                                              21 Healthy controls                           Monetary decision-making task                       Evaluation of modular connectivity of each subjects' NAc                           •Significantly higher sensitivity in CBP patients•Correlation between sensitivity and connectivity within NAc module (with strong connections to the frontal cortex) described by healthy controls•No correlation between sensitivity and connectivity within NAc module (strong connections to subcortical areas) described by CBP patients•High similarity in connectivity between CBP patients and this study's highly impulsive healthy subjects•Strong correlation between the brain systems that support chronic pain and reward processing•Prediction of the range of behaviors (from simple to complex) from brain activity during rest based on the precedence
  [@B27]             Task fMRI                          11 Idiopathic CLBP, 16 fibromyalgia                                 11 Healthy controls                           Pressure at neutral site                            Sensory testing and regional activation of cortex                                  •Hyperalgesia in CLBP and fibromyalgia groups•Slightly higher intense pain in the controls than in the CLBP patients with or the with fibromyalgia patients•Applying equal amounts of pressure results in five common detected regions of neuronal activation in pain-related cortical areas including the contralateral S1 and S2, inferior parietal lobule, ipsilateral S2, and cerebellum in CLBP and fibromyalgia patients•Common neuronal activations in three groups when exposing the subjects to the stimuli which evoked subjectively similar pain
  [@B37]             Task fMRI                          13 CLBP                                                             13 Healthy controls                           Non-painful posterior--anterior movement pressure   Reorganization in the S1 and S2 cortices following mechanosensory stimuli          •No cortical reorganization in S1 after stimulation•Reduced activation of S2 in both hemispheres in CLBP patients•Observed a blurring of the somatotopic representation of the lumbar spine in S2 in CLBP patients
  [@B51]             Task fMRI                          36 CLBP                                                             36 Healthy controls                           MSIT                                                Cingulo-frontal-parietal cognitive/attention network                               •Less activation in the CFP network including the dlPFC, dorsal ACC, and bilateral SPC in attention-demanding task•Low response accuracy in interference trials•A significant negative correlation between the VAS score of pain and activation of the right PFC during performing the MSIT in CLBP patients

MRI, magnetic resonance imaging; fMRI, functional magnetic resonance imaging; CBP, chronic back pain; CLBP, chronic low back pain; NSLBP, non-specific low back pain; CRPS, complex regional pain syndrome; OA, osteoarthritis; GM, gray matter; WM, white matter; ROI, region of interest; FC, functional connectivity; VAS, visual analog scale; MSIT, multi-source interference task; DMN, default-mode network; STSTS, sit-to-stand-to-sit task; NAc, nucleus accumbens; rCBF, regional cerebral blood flow; PFC, prefrontal cortex; dlPFC, dorsolateral prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; vmPFC, ventral medial prefrontal cortex; dmPFC, dorsal medial prefrontal cortex; mPFC, medial prefrontal cortex; MCC, middle cingulate cortex; PCC, posterior cingulate cortex; LPC, lateral parietal cortex; DMN, default-mode network; INS, insula; PAG, periaqueductal gray; rACC, rostral anterior cingulate cortex; S1, primary sensory cortex; S2, secondary sensory cortex; SPC, superior parietal cortex.

###### 

Evaluation of cortical alterations in CBP patients using EEG and MEG techniques.

  **Author, year**   **Scan type**   **Patients**     **Controls**            **Stimulation**                                                                                                           **Main findings**
  ------------------ --------------- ---------------- ----------------------- ------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B20]             EEG             14 CLBP          13 Healthy controls     Electrical stimuli                                                                                                        •Larger N80 component after stimulation•No significant group difference in the N150 component•Smaller P260 component after stimulation•Positive correlation between N80/N150 amplitudes and perceptual sensitization•Increased perceptual sensitization and increased processing of the sensory-discriminative aspect (N80 component) of pain in patients
  [@B24]             EEG             16 CBP, 16 THA   16 Healthy controls     Electrical stimuli                                                                                                        •Significantly lower pain threshold and pain tolerance in CBP patients compared with THA patients and healthy controls•Reduced habituation in CBP patients•No significant differences in amplitudes of N150, P260, P300, and N500 among three groups•Lower stimulation intensity in CBP patients
  [@B22]             EEG and MEG     10 CBP           Nine healthy controls   Standard intracutaneous electrical stimuli to the left back and index finger with a non-painful and a painful intensity   •Enhanced power of the evoked early magnetic field (\< 100 ms) in LBP patients than healthy controls following painful back stimulation•Medial shift in the maximum activity elicited in the S1 in LBP patients
  [@B23]             EEG             12 CBP           12 Healthy controls     Pain- and body-related verbal materials                                                                                   •No more recognition of patients in the pain-related words•Enhanced N100 and N200 of the left hemisphere to pain-related words, when compared to neutral words•A positive shift to all words extending into the 800 ms range•No distinct P300 in CBP patients•Enhanced levels of skin conductance to the pain-related words
  [@B70]             EEG             12 CLBP          12 Healthy controls     IGT                                                                                                                       •Lower scores of cognitive measures (MCST) in CLBP patients influenced by pain intensity and duration•Worse performance and the absence of a learning process during the behavioral IGT test with no effect of pain features in CLBP patients•Poor performance in the MCST and the IGT in CLBP patients•The FRN amplitude in wins was higher than in losses in controls, while the opposite happened in CLBP patients•The P300 amplitude was higher in wins than in losses in controls, while there was no difference in CLBP patients
  [@B80]             EEG             10 CBP           Nine healthy controls   Electrical stimulation                                                                                                    •Somatotopic organization of the S1•Correlation between the amount of reorganization and pain rating

EEG, electroencephalography; MEG, magnetoencephalography electromyographic activity; ms, millisecond; CBP, chronic back pain; CLBP, chronic low back pain; THA, tension headache; MCST, modified card sorting test; IGT, Iowa gambling task; ERPs, event-related potentials.

###### 

Evaluation of cortical alterations in CBP patients using the MRS technique.

  **Author, year**   **Methods**   **Patients**                       **Controls**          **Main findings (patients compared with controls)**
  ------------------ ------------- ---------------------------------- --------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B28]             ^1^H-MRS      Nine CLBP                          11 Healthy controls   •Alterations in the human brain chemistry in patients•Decreased NAA and Glu in the dlPFC•No chemical concentration differences in brain regions, such as the cingulate, sensorimotor, etc.•Abnormal interrelationship between chemicals within and across brain regions•A specific correlation between regional chemical concentration and perceptual scores of anxiety and pain
  [@B29]             ^1^H-MRS      Nine CBP                           16 Healthy controls   •Alterations in NAA levels of the dlPFC and OFC•Correlations between the levels of brain regional NAA (the OFC and dlPFC) and perceptual measures of pain in CBP patients•Correlation between the NAA changes of the OFC and measures of anxiety in CBP patients
  [@B30]             ^1^H-MRS      12 CLBP with symptoms of anxiety   16 Healthy controls   •An exact correlation between perception and brain chemical contents•The dlPFC and OFC were considered as the best related chemical-perceptual network to pain•The relationship between chemical-anxiety networks was best related to the OFC chemistry in controls and to the dlPFC, OFC, cingulate, and thalamus in CLBP patients•The region best related to the affective component of pain was the cingulate cortex
  [@B31]             ^1^H-MRS      10 CBP with depression             10 Healthy controls   •Decreased NAA levels in the right dlPFC•Strong correlation between depression levels of CBP patients and the levels of NAA levels in the right dlPFC•Weak correlation between the levels of pain levels and levels of NAA in the right dlPFC of CBP patients (compared to depression-NAA correlations)
  [@B32]             ^1^H-MRS      10 CLBP                            10 Healthy controls   •Decreased levels of Glu in the ACC•Decreased levels of Gln in the anterior INS, ACC, and thalamus•Decreased levels of NAA in the anterior INS and ACC•Decreased levels of mI was reduced in the ACC and thalamus•No significant changes for Cr
  [@B68]             ^1^H-MRS      11 CLBP                            11 Healthy controls   •Correlations between metabolite concentrations and pain characteristics•Decreased NAA and Cho in the left S1•Lower correlations between all metabolites (NAA, Cho, mI, Glu, and Gln) in the right S1•Higher and significant correlations between left and right mI levels and between left mI and right Cho•Negative correlation between left and right NAA levels and pain duration•Positive correlation between right Glu/Gln concentrations and pain severity•Significant changes in the neuronal--glial interactions in S1
  [@B67]             ^1^H-MRS      19 CLBP                            14 Healthy controls   •Lower right M1 NAA•No significant differences in the Left M1 NAA and mI•No significant correlations between pain characteristics and M1 neurochemical contents
  [@B69]             ^1^H-MRS      32 CLBP                            33 Healthy controls   •Significant differences in the chemical levels of ACC, thalamus, and PFC of patients compared with the ones of healthy subjects with accuracies of 100%, 99%, and 97%, respectively

1

H-MRS, single-voxel proton magnetic resonance spectroscopy; CBP, chronic back pain; CLBP, chronic low back pain; NAA,

N

-acetyl aspartate; Glu, glutamate; Gln, glutamine; Cr, creatine; mI, myo-inositol; Cho, choline; PFC, prefrontal cortex; dlPFC, dorsolateral prefrontal cortex; OFC, orbital frontal cortex; INS, insula; S1, primary somatosensory cortex; M1, primary motor cortex.

Structural and Functional MRI Studies {#S2.SS1}
-------------------------------------

The structural MRI could provide anatomical information of the brain with high spatial resolution, and the functional MRI (fMRI) is used to determine the location of the "activate" brain regions during cognitive tasks ([@B1]; [@B46]; [@B40]; [@B63]). Both techniques are helpful to provide information about brain organization and offer potential new criteria for assessing the neurological status and neurosurgical risk; thus they are widely employed to characterize structural or functional brain alterations among CBP patients under clinical settings ([@B79]; [@B55]). Since these neuroimaging techniques have distinct advantages, we reviewed studies that explore the cortical abnormalities in CBP patients using structural MRI, resting state fMRI, and task fMRI, respectively.

By extracting morphological features from structural MRI through some advanced analysis techniques (e.g., voxel-based morphometry), several crucial anatomical changes have been observed in CBP patients. In a pilot study, CBP patients exhibited decreased neocortical gray matter (GM) volume (5--11% less than healthy controls), with the magnitude equivalent to the loss quantity caused by 10--20 years of normal aging ([@B3]). Meanwhile, several studies have reported that the GM density of CBP patients was significantly reduced in a series of pain-related brain regions, including the dorsolateral prefrontal cortex (dlPFC) ([@B3]; [@B64]; [@B26]), dorsomedial prefrontal cortex (dmPFC) ([@B26]), ventrolateral prefrontal cortex (vlPFC) ([@B26]), ventromedial prefrontal cortex (vmPFC) ([@B26]), primary somatosensory cortex (S1) ([@B64]; [@B5]; [@B41]), secondary somatosensory cortex (S2) ([@B64]; [@B5]; [@B41]), insula (INS) ([@B5]; [@B26]), middle cingulate cortex ([@B41]), thalamus ([@B3]; [@B41]), and brainstem ([@B64]). Please note that these brain regions are also functionally associated with some clinical symptoms (e.g., subjective ratings of pain intensity, emotional disorders, and cognitive impairments) of CBP, and the relevant findings are detailed in the following paragraphs. In addition, the GM densities of some brain regions (dorsal rostral pons and somatosensory cortices) demonstrated significant negative correlations with both the subjective ratings of pain intensity and unpleasantness ([@B64]). Importantly, the structural abnormalities in the brain can be reversed by effective CBP treatments. For example, increased cortical thickness in the left dlPFC after treatment could be observed in CBP patients compared to that before treatment, and such improvement in brain structure was positively correlated with the reduction of pain and physical disability ([@B66], [@B65]). All these morphological findings indicated that CBP is accompanied by brain atrophy in regions commonly associated with pain processing and modulation, which has a great influence on pain chronicity ([@B45]).

As an effective technique to map white matter (WM) tractography in the brain ([@B57]; [@B11]), diffusion tensor imaging (DTI) has been used to study the WM architecture and integrity in CBP patients ([@B13]; [@B14]). Lower WM integrity of the splenium of the corpus callosum was found in disabled CBP patients ([@B13]), and importantly, negative correlation between total months of CBP and WM integrity of the splenium of the corpus callosum was observed. In addition, Vania Apkarian and his colleagues tracked brain properties in subacute back pain patients longitudinally for 1 year ([@B49]) and 3 years ([@B75]), as their pain either recovered or transitioned to chronic pain. Testing the role of the corticolimbic system in the development of CBP, Vania Apkarian and his colleagues observed that the dorsal medial prefrontal cortex (mPFC)-amygdala-nucleus accumbens network contributing to risk of chronic pain, which suggested that corticolimbic neuroanatomical factors were important features to predispose subacute back pain patients to recover from or transition to chronic pain ([@B75]).

The resting state fMRI and task fMRI are normally applied to investigate functional alterations in CBP patients by measuring the spontaneous blood-oxygen-level dependent (BOLD) activities of brain networks at resting state ([@B6]; [@B10]; [@B73]; [@B82]) and the evoked BOLD responses during pre-defined tasks/stimuli ([@B1]; [@B46]), respectively. Previous studies using resting state fMRI revealed that CBP patients exhibited reduced deactivation in the mPFC, amygdala, and posterior cingulate cortex, which were considered as key brain regions in the default mode network (DMN) ([@B7]). The disruptions of the DMN were related to the cognitive and behavioral impairments associated with chronic pain ([@B7]). Additionally, the resting state functional connectivity (FC) of the DMN network was reported to be influenced by negative mood in CBP patients, which implied that the abnormalities of the DMN were related to the information processing of affective-motivational aspect of pain ([@B44]). Apart from the DMN network, decreased resting state FC of the sensorimotor network was also observed in CBP patients, which was associated with the performance of a dynamic sensorimotor task (i.e., the duration of performing the sit-to-stand-to-sit task) ([@B58]). Notably, increased resting state FC between periaqueductal gray (PAG, a key region in the descending pain modulation pathway) and vmPFC/rostral anterior cingulate cortex (ACC) was represented in CBP patients compared to the one in healthy controls, suggesting an abnormal function of the PAG-centered descending pain modulation system in CBP patients ([@B81]). Additionally, abnormal FC between mPFC/ACC and brain regions within the DMN was observed in CBP patients, and the abnormal FC was also found to be correlated with pain duration, pain severity, and pain interference ([@B71]). Importantly, Vania Apkarian and his colleagues focused on investigating the neural mechanism associated with pain chronification, and obtained several novel findings. For example, they found that corticostriatal FC (between nucleus accumbens and prefrontal cortex) is an accurate predictor of the transition from acute to chronic pain ([@B9]; [@B75]). In addition, they observed that brain activity associated with acute/subacute back pain is limited to regions involved in acute pain, while brain activity related to chronic pain is confined to emotion-related circuitry ([@B34]). This observation suggested that brain representation for back pain can undergo large-scare shifts in brain activity with pain chronification.

Consistently, evidence from the task fMRI revealed that CBP patients exhibited abnormal brain functions related to pain processing ([@B27]). For example, relative to the healthy controls, the CBP patients reported significant higher pain intensity when received painful pressure with fixed physical intensity, and showed stronger activations in several pain-related brain regions, including the contralateral S1, bilateral S2, inferior parietal lobule, and cerebellum ([@B27]), which indicated that CBP patients have increased pain sensitivity. In contrast, when receiving non-painful movement pressure, CBP patients showed a decreased somatosensory acuity and reduced activations of bilateral S2, suggesting a reorganization of higher order processing of sensory information in these patients ([@B37]). In addition, brain dysfunction in emotional and cognitive disorders caused by the maladaptation to chronic pain was frequently reported ([@B66]; [@B12]; [@B51]). For example, in an attention-demanding cognitive task, the impaired cognitive ability and abnormal activation of cingulo-frontal-parietal (CFP) cognitive/attention network ([@B51]), especially in the dlPFC ([@B66]), were observed in CBP patients. Further, risky monetary behavior and altered connectivity of the nucleus accumbens (a key brain region in reward processing) were observed in CBP patients ([@B12]), and such observation has been interpreted as a consequence of cognitive disorders or comorbidity of chronic pain.

EEG and MEG Studies {#S2.SS2}
-------------------

Different from MRI techniques that could provide massive spatial information related to cortical regions/networks involved in pain processing, EEG/MEG techniques can measure the cortical changes with a high temporal resolution, thus giving a deep insight into the dynamic process of pain information processing ([@B15]; [@B43]). Nowadays, crucial progress has been made in the evaluation of cortical dysfunction in CBP patients with EEG/MEG techniques. It is generally accepted that the central sensitization (represented by reduced pain threshold, pain tolerance, and increased perceived pain intensity) and the cortical processing of the sensory-discriminative aspect of pain were significantly enhanced in CBP patients ([@B23], [@B24]; [@B20]). For example, a larger amplitude of the early N80 component in somatosensory event-related potentials (ERPs) elicited by painful electrical intramuscular and intracutaneous stimuli was observed in CBP patients ([@B20]), indicating a central sensitization among these patients. Accordingly, when receiving intracutaneous electrical painful stimuli, CBP patients showed significant larger power of early evoked MEG response than healthy controls did, and the power of this early response was positively correlated with the chronicity in CBP patients ([@B22]), which provided a strong evidence that pain chronicity is accompanied with central sensitization, resulting in the abnormal information processing of the sensory-discriminative aspect of pain ([@B22]; [@B20]).

In addition, CBP patients showed evident abnormalities in emotional and cognitive functions. For example, when being assessed the emotional decision-making abilities using the Iowa gambling task, CBP patients scored much lower than healthy controls did, and their performance was significantly influenced by the duration and intensity of their chronic pain ([@B70]). Consistent with this behavioral result, the ERP data showed abnormal feedback processing in CBP patients during the Iowa gambling task ([@B70]). Specifically, the amplitude of feedback-related negativity (FRN) was higher in wins than in losses in healthy controls, while the opposite results were obtained in CBP patients; the amplitude of P300 was higher in wins than in losses in healthy controls, whereas no significant difference was observed in CBP patients. The abnormal feedback cognitive processing resulting in the impairments in the work and family settings were often reported by CBP patients ([@B70]). Moreover, CBP patients showed a lower amplitude of the later P260 component in somatosensory ERPs evoked by painful electrical stimuli, which also suggested the deficiency of higher cognitive functions in CBP patients (e.g., the function related to affective distress) ([@B20]).

Accompanied by the long-term changes of cortical function, cortical reorganization in CBP patients due to the processes of neuronal plasticity was well documented ([@B22]; [@B80]). Demonstrated by an MEG study, alterations in the somatotopic organization of the S1 were observed in CBP patients ([@B80]). Specifically, being elicited by intracutaneous electrical stimuli with different intensities (from non-painful to painful), the maximal response in the primary somatosensory cortex was shifted more medially in CBP patients than in healthy controls ([@B22]). Importantly, such brain reorganization was correlated with subjective pain ratings ([@B80]). In summary, chronic pain is accompanied by cortical reorganization, an important neural marker indicating the persistence of the pain experience and the dysfunction of cortical processing. However, the potential relationships between findings obtained using EEG/MEG and MRI techniques in evaluating cortical alterations in CBP patients remain to be elucidated.

MRS Studies {#S2.SS3}
-----------

Chemical changes in the brain of CBP patients can be detected using *in vivo* single-voxel proton MRS (^1^H-MRS), which is able to provide additional evidence on abnormal brain alterations associated with chronic pain ([@B32]; [@B83]). Several MRS studies showed that a reduced level of *N*-acetyl aspartate (NAA) was observed in several brain regions of CBP patients, including the dlPFC, orbitofrontal cortex (OFC), anterior INS, ACC, and thalamus ([@B28], [@B31]; [@B32]; [@B68], [@B67]). In addition, some studies reported that CBP patients had reduced levels of glutamate (Glu) in the ACC ([@B32]), glucose in the dlPFC ([@B28]), and myo-inositol (mI) in the ACC and thalamus ([@B32]). These brain chemical imbalances were negatively correlated with pain intensity in CBP patients ([@B28]). Importantly, certain changes in brain chemistry were shown to be highly correlated with psychological factors ([@B69]). For example, the levels of NAA in the right dlPFC and OFC were, respectively, correlated with depression ([@B31]) and anxiety ([@B29], [@B30]) levels in CBP patients. Therefore, it would be reasonable to hypothesize that brain chemistry changes play an important role in the development and maintenance of CBP and its comorbidity (e.g., depression and anxiety) ([@B28], [@B29], [@B30], [@B31]). Given that the reduced Glu level may indicate disordered glutamatergic neurotransmission, and the reduced levels of NAA and mI could be related to the loss of neurons and glial cells ([@B32]), these alterations in the brain biochemical profile in CBP patients could represent the cortical reorganization caused by long-term pain suffering ([@B28], [@B29], [@B30], [@B31]).

Discussion {#S3}
==========

Chronic back pain is a substantial worldwide health problem. The need for treatment of CBP based on a deeper understanding of its causes and outcomes is urgent and pressing in clinic. Considering that chronic pain is associated with several psychological disorders (e.g., depression, anxiety, and sleep disturbances) involving cortical dysfunction, more and more researchers shift their interests from the peripheral level to the cortical level. With the development of non-invasive neuroimaging techniques, a series of novel findings were obtained in this field.

First, despite CBP patients have sensorimotor impairments (e.g., decreased sensitivity to innocuous stimuli), they have enhanced central sensitization to external painful stimuli, manifested by increased subjective pain sensitivity and increased brain activations in pain-related brain regions. It has been reported that increased pain sensitization and decreased sensitivity to innocuous stimuli in CBP patients are associated with increased catastrophizing, which is also linked with increased clinical back pain ([@B53]). This central sensitization could serve as an overgeneralized protective function to prevent the injured spinal cord from being irritated by the harmful sensory inputs ([@B2]). However, since the nociceptive signals induced by external stimuli could be amplified in the ascending pain modulation pathway at any level (e.g., the spinal cord, brainstem, and cerebral cortex), we could not determine the site of central sensitization based on the observation of overactivation in the brain ([@B2]). In other words, the perceptual sensitization observed in the human brain could be caused by the changes in sensitivity of the spinal cord, of which the nociceptive information was amplified before propagated to the cortex. Integration of spinal cord and brain MRI/fMRI techniques is warranted to solve this issue ([@B79]; [@B55]), which could also allow us to identify relevant neural mechanisms to determine the target site for optimizing the CBP intervention ([@B79]; [@B55]).

Second, suffering from chronic pain, CBP patients commonly exhibited emotional and cognitive disorders, including depression, anxiety, catastrophizing, and sleep disturbances ([@B7]). In line with these dysregulations, cortical abnormalities have been frequently observed in the regions, pathways, and networks associated with neural processing of emotional and cognitive information in CBP patients ([@B29], [@B30], [@B31]; [@B7]; [@B44]). In addition to the physiological and psychological factors that are important for the development and maintenance of chronic pain, a biopsychosocial model of pain, which also highlighted the social factors (e.g., interpersonal relationship), has been proposed to better identify the mechanisms of chronic pain ([@B56]). Importantly, the biopsychosocial model describes pain as a multidimensional and dynamic integration of physiological, psychological, and social factors, which are needed to be considered in the development, maintenance, and treatment of chronic pain ([@B61]; [@B56]). Indeed, more neuroimaging studies under the framework of the biopsychosocial model should be conducted in the future to achieve a comprehensive and sophisticated understanding of the neural mechanisms related to the causes and outcomes of CBP.

Additionally, accumulating evidence has demonstrated that CBP is associated with clear cortical reorganization and neuronal plasticity, which is normally quantified by structural (e.g., GM volume and density) ([@B3]), functional (e.g., cortical representation of the body, brain abnormalities of cortical regions and networks) ([@B7]; [@B37]), and metabolic (e.g., levels of NAA, Glu, and mI) ([@B28], [@B29], [@B30], [@B31]; [@B32]) changes in the brain. Interestingly, the cortical reorganization is reversible by effective treatment ([@B66], [@B65]), suggesting that the quantified brain changes could be used as important neural indicators to monitor the progress of CBP development and to evaluate the effectiveness of CBP treatments, such as acupuncture ([@B35]; [@B72]), placebo ([@B74]), and other pain management approaches ([@B54]; [@B25]).

To sum up, with the development of neuroimaging techniques, great progress has been made to improve our understanding of cortical alterations in CBP patients over the past few years. However, the neural mechanisms associated with the development of CBP remain largely mysterious, which hampers the improvement of the efficacy of CBP treatment. To address this issue, integration of neuroimaging techniques and other biotechnologies (e.g., genetic testing and psychological testing) would be important to achieve a comprehensive assessment of the risk factors (e.g., genetics, injuries, and mental health problems) of the development and maintenance of CBP. In addition, longitudinal studies are highly needed to assess the temporal relationship between chronic pain and neural plasticity. It is worthwhile to note that longitudinal studies would not only improve our understanding of the neural mechanisms associated with the causes and outcomes of CBP but also provide theoretical bases for accurate diagnoses of CBP patients. Integrating the results obtained from comprehensive and longitudinal studies is a promising way to identify the causes of pain and pain-associated comorbidities and deepen our understanding of the mechanisms involved in chronic pain, and ultimately promotes the development of more appropriate and effective treatments in CBP management.
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